| 1 |
31734352 | Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells. | 2020 Jan 28 |
3 |
| 2 |
21314483 | Role of hTERT and WT1 gene expression in disease progression and imatinib responsiveness of patients with BCR-ABL positive chronic myeloid leukemia. | 2011 Apr |
1 |
| 3 |
21356308 | Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1. | 2011 Jul |
1 |
| 4 |
21364010 | hTERT promotes imatinib resistance in chronic myeloid leukemia cells: therapeutic implications. | 2011 May |
3 |
| 5 |
18569639 | Leukemic cells with increased telomerase activity exhibit resistance to imatinib. | 2008 Jun |
1 |
| 6 |
17545631 | BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells. | 2007 Jun 1 |
1 |
| 7 |
16498395 | hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia. | 2006 Apr |
1 |
| 8 |
15850831 | Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib. | 2005 May |
3 |